Starting with macrocycles and mini-binders. Can't wait for your feedback!

More to come! For requests beyond current platform capabilities: partnerships@latentlabs.com.

What excites me most: getting this into the hands of scientists through our no-code platform. Replicates our validated workflows, no AI background required.

And it’s fast — up to 10x faster than prior methods!

Latent-X generates novel binders from scratch, solving the geometric puzzle of binding at the all-atom level while obeying biochemical rules nature follows.

I'm still mesmerized watching the model generate successful binders directly at the atom level — hydrogen bonds included!

Latent-X achieved breakthrough lab results:

Picomolar binding affinities, directly outperforming prior methods in head-to-head validation.

Leading experimental hit rates:
* 91-100% for macrocycles
* 10-64% for mini-binders

Testing 30-100 designs per target vs millions traditionally.

Introducing Latent-X — our all-atom frontier AI model for protein binder design.

State-of-the-art lab performance, widely accessible via the Latent Labs Platform.

Free tier: platform.latentlabs.com
Blog: latentlabs.com/latent-x/
Technical report: tinyurl.com/latent-X

Latent Labs comes out of stealth today with $50M funding. Our goal? To push the frontiers of generative biology, giving partners instant access to tools capable of accelerating drug design